KFSHRC Formalises Five International Agreements To Enhance Medical Innovation At Saudi-US Investment Forum

King Faisal Specialist Hospital & Research Centre (KFSHRC) has entered into five significant international agreements at the Saudi-US Investment Forum 2025. This move highlights its dedication to medical innovation and global partnerships. The agreements were signed during a roundtable titled "Next-Generation Healthcare: Saudi-US Collaboration in Biotechnology and Digital Health" at the King Abdulaziz International Conference Center in Riyadh.

The agreements include a memorandum of understanding with Cleveland Clinic, focusing on autism and neuroscience. Another agreement involves a tripartite collaboration with Qiddiya Investment Company and Cleveland Clinic in sports medicine and performance. Additionally, KFSHRC is partnering with Germfree for advanced laboratory development, Medtronic for cardiac center equipment, and ImmunityBio for a national biotechnology platform in immunotherapy.

Dr. Majid bin Ibrahim AlFayyadh, CEO of KFSHRC, expressed gratitude for the support from Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and Crown Prince Mohammed bin Salman bin Abdulaziz Al Saud. He noted that their backing has enabled KFSHRC to emerge as a leading global healthcare institution. Dr. AlFayyadh highlighted the hospital’s journey towards clinical excellence, research enhancement, education improvement, and financial sustainability aligned with Saudi Vision 2030.

KFSHRC is committed to adopting advanced medical technologies like CAR-T cell therapy and robotic surgeries. These innovations reduce the need for patients to seek treatment abroad, solidifying the Kingdom's status as a regional hub for specialized healthcare. The hospital's expertise in organ transplantation and personalized medicine further supports this goal.

The strategic agreements reflect KFSHRC’s dedication to fostering innovation and international cooperation while supporting technology localization and healthcare advancement in the Kingdom. This commitment aligns with Saudi Vision 2030's goals of improving spending efficiency and ensuring high-quality treatment outcomes through investment in advanced medical technologies.

Recognition and Rankings

KFSHRC has been ranked first in the Middle East and North Africa region and 15th globally among the world’s top 250 Academic Medical Centres for two consecutive years. It is also recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East according to Brand Finance's 2024 rankings.

In addition to these accolades, KFSHRC was listed among the world's best 250 hospitals by Newsweek magazine for 2025. It was also included in their World’s Best Smart Hospitals list, highlighting its commitment to integrating smart technologies into healthcare practices.

The hospital's efforts underscore its role as a leader in healthcare innovation, both regionally and globally. By strengthening strategic partnerships and investing in cutting-edge treatments, KFSHRC continues to enhance its capabilities while contributing significantly to Saudi Arabia's healthcare sector.

With inputs from SPA